Etomidate
- Generic Name
- Etomidate
- Brand Names
- Amidate
- Drug Type
- Small Molecule
- Chemical Formula
- C14H16N2O2
- CAS Number
- 33125-97-2
- Unique Ingredient Identifier
- Z22628B598
Overview
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Background
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Indication
Used in the induction of general anesthesia.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
etomidate
Manufacturer:Zydus Lifesciences Limited
Route:INTRAVENOUS
Strength:2 mg in 1 mL
Approved: 2022/10/17
NDC:65841-818
ETOMIDATE injection, solution
Manufacturer:HF Acquisition Co LLC, DBA HealthFirst
Route:INTRAVENOUS
Strength:20 mg in 10 mL
Approved: 2023/09/25
NDC:51662-1634
Etomidate
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:2 mg in 1 mL
Approved: 2021/07/14
NDC:65219-445
Etomidate
Manufacturer:Gland Pharma Limited
Route:INTRAVENOUS
Strength:2 mg in 1 mL
Approved: 2017/10/17
NDC:68083-234
Etomidate
Manufacturer:Gland Pharma Limited
Route:INTRAVENOUS
Strength:2 mg in 1 mL
Approved: 2017/10/17
NDC:68083-235
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath